Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.


Journal

Genes & development
ISSN: 1549-5477
Titre abrégé: Genes Dev
Pays: United States
ID NLM: 8711660

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 14 05 2019
accepted: 12 08 2019
pubmed: 7 9 2019
medline: 20 11 2019
entrez: 7 9 2019
Statut: ppublish

Résumé

The histone methyltransferase activity of PRC2 is central to the formation of H3K27me3-decorated facultative heterochromatin and gene silencing. In addition, PRC2 has been shown to automethylate its core subunits, EZH1/EZH2 and SUZ12. Here, we identify the lysine residues at which EZH1/EZH2 are automethylated with EZH2-K510 and EZH2-K514 being the major such sites in vivo. Automethylated EZH2/PRC2 exhibits a higher level of histone methyltransferase activity and is required for attaining proper cellular levels of H3K27me3. While occurring independently of PRC2 recruitment to chromatin, automethylation promotes PRC2 accessibility to the histone H3 tail. Intriguingly, EZH2 automethylation is significantly reduced in diffuse intrinsic pontine glioma (DIPG) cells that carry a lysine-to-methionine substitution in histone H3 (H3K27M), but not in cells that carry either EZH2 or EED mutants that abrogate PRC2 allosteric activation, indicating that H3K27M impairs the intrinsic activity of PRC2. Our study demonstrates a PRC2 self-regulatory mechanism through its EZH1/2-mediated automethylation activity.

Identifiants

pubmed: 31488577
pii: gad.328773.119
doi: 10.1101/gad.328773.119
pmc: PMC6771381
doi:

Substances chimiques

Histones 0
Protein Subunits 0
Polycomb Repressive Complex 2 EC 2.1.1.43
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1428-1440

Subventions

Organisme : NCI NIH HHS
ID : R01 CA199652
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA024837
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM110174
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009140
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA196539
Pays : United States

Informations de copyright

© 2019 Lee et al.; Published by Cold Spring Harbor Laboratory Press.

Références

Mol Cell. 2013 Oct 24;52(2):255-63
pubmed: 24055344
Genes Dev. 2013 May 1;27(9):985-90
pubmed: 23603901
Mol Cell. 2015 Mar 5;57(5):769-783
pubmed: 25620564
Nature. 2018 Aug;560(7719):504-508
pubmed: 30051891
Genes Dev. 2019 Oct 1;33(19-20):1416-1427
pubmed: 31488576
Nat Med. 2017 Apr;23(4):493-500
pubmed: 28263307
Science. 2013 May 17;340(6134):857-61
pubmed: 23539183
J Biol Chem. 2017 Aug 11;292(32):13323-13332
pubmed: 28607149
Hum Mutat. 2017 Jun;38(6):637-648
pubmed: 28229514
PLoS One. 2013 Dec 19;8(12):e83737
pubmed: 24367611
Mol Cell. 2016 Nov 17;64(4):659-672
pubmed: 27863226
Mol Cell. 2018 May 3;70(3):422-434.e6
pubmed: 29681499
Genes Dev. 2019 Aug 1;33(15-16):903-935
pubmed: 31123062
Curr Protoc Bioinformatics. 2012 Dec;Chapter 13:Unit13.20
pubmed: 23255153
Science. 2002 Nov 1;298(5595):1039-43
pubmed: 12351676
Nature. 2012 Dec 6;492(7427):108-12
pubmed: 23051747
FEBS Lett. 2011 Oct 3;585(19):3011-4
pubmed: 21856302
Nucleic Acids Res. 2009 May;37(9):2940-50
pubmed: 19293275
Biochem J. 2002 Dec 15;368(Pt 3):947-52
pubmed: 12190618
Cell. 2002 Oct 18;111(2):197-208
pubmed: 12408864
Genes Dev. 2002 Nov 15;16(22):2893-905
pubmed: 12435631
Blood. 2011 Feb 24;117(8):2451-9
pubmed: 21190999
Nat Struct Mol Biol. 2017 Dec;24(12):1028-1038
pubmed: 29058709
Science. 2015 Oct 16;350(6258):aac4383
pubmed: 26472914
Nat Genet. 2014 Nov;46(11):1227-32
pubmed: 25240281
Mol Cell. 2018 May 3;70(3):435-448.e5
pubmed: 29681498
Neuro Oncol. 2019 Mar 29;:
pubmed: 30923826
Nature. 2009 Oct 8;461(7265):762-7
pubmed: 19767730
Mol Cell. 2018 Mar 1;69(5):840-852.e5
pubmed: 29499137
Nat Commun. 2016 Apr 28;7:11316
pubmed: 27121947
Nucleic Acids Res. 2007;35(21):7313-23
pubmed: 17962312
Mol Cell. 2018 May 3;70(3):408-421.e8
pubmed: 29628311
Nat Med. 2012 Feb 06;18(2):298-301
pubmed: 22237151
Nature. 2017 Sep 14;549(7671):287-291
pubmed: 28869966
Elife. 2017 Nov 29;6:
pubmed: 29185984
Nat Commun. 2019 Mar 19;10(1):1262
pubmed: 30890717
Methods Mol Biol. 2012;833:237-53
pubmed: 22183598
Sci Adv. 2018 Oct 31;4(10):eaau5935
pubmed: 30402543
Nat Med. 2017 Apr;23(4):483-492
pubmed: 28263309
Science. 2018 Jul 6;361(6397):33-34
pubmed: 29976815
J Biol Chem. 2013 Sep 27;288(39):27872-80
pubmed: 23946480
Mol Cell. 2016 Nov 17;64(4):645-658
pubmed: 27863225
Genes Dev. 2013 Dec 15;27(24):2663-77
pubmed: 24352422
Nat Cell Biol. 2008 Nov;10(11):1291-300
pubmed: 18931660
Science. 2018 Feb 23;359(6378):940-944
pubmed: 29348366
Mol Cell. 2018 Jun 21;70(6):1149-1162.e5
pubmed: 29932905
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2488-93
pubmed: 24550272
Nat Genet. 2010 Feb;42(2):181-5
pubmed: 20081860
Mol Cell. 2008 Nov 21;32(4):503-18
pubmed: 19026781
Nat Commun. 2016 Apr 28;7:11384
pubmed: 27122193
Nat Commun. 2019 May 13;10(1):2146
pubmed: 31086175

Auteurs

Chul-Hwan Lee (CH)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Jia-Ray Yu (JR)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Jeffrey Granat (J)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Ricardo Saldaña-Meyer (R)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Joshua Andrade (J)

Proteomics Laboratory, New York University School of Medicine, New York, New York 10016, USA.

Gary LeRoy (G)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Ying Jin (Y)

Shared Bioinformatics Core, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

Peder Lund (P)

Department of Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

James M Stafford (JM)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Benjamin A Garcia (BA)

Department of Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Beatrix Ueberheide (B)

Proteomics Laboratory, New York University School of Medicine, New York, New York 10016, USA.

Danny Reinberg (D)

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH